{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJvcvdAJDA","lastupdate":"2022-09-04T00:00:00.000Z","update_date":"2022-09-04T00:00:00.000Z","lastModified":"Oct 5, 2025","active":1,"confidence_score":98,"confidence_score_reason":"video or image, markets","urlname":"ukko","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$BhBe0G4xYOtNeEVW8Z6pftsPckL76OqaHmPYNk2mumwwRKjcUNNM3T","name":"Ukko","oneliner":"Safer Proteins for People with Food Allergies and Sensitivities","registrar":"515685550","website":"https://www.ukko.us/","careerspage":"","founded_month":5,"founded_year":2016,"formernames":[],"sociallinks":{"twitter":"https://mobile.twitter.com/ukko_inc","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/18374287","instagram":""},"social":["https://www.linkedin.com/company/18374287","https://mobile.twitter.com/ukko_inc"],"flattenedsociallinks":"https://www.linkedin.com/company/18374287|https://mobile.twitter.com/ukko_inc","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"51-200","employees_exact":51,"patent":0,"raised":47700000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","primary_sector":"Agriculture & Food Technologies","alternativenames":["My Ukko"],"about":"Ukko's mission is to improve the lives of people with food allergies and sensitivities. Ukko uses immunology, machine learning, and protein engineering to make measurably better and safer proteins for use in food and therapeutics. Ukko does this by designing and controlling the molecular interactions between allergen proteins and the immune system. \r\n\r\nUkko's technology uses samples from patients and machine learning to guide the engineering of superior proteins that can be incorporated into food products and therapeutics. These proteins maintain or improve beneficial properties (taste, nutritional value, yield, and physicochemical and mechanical properties) but do not trigger an immune response. Ukko's initial product pipeline includes celiac-safe gluten proteins, allergy-safe and therapeutic peanut proteins, as well as a pipeline of additional allergen proteins.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"eff8e904-3ac8-40d4-822b-c0c33a06f394","city":"Rehovot","type":null,"address":"HaMada Street 12, Rehovot, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"bccbcaeb-756e-4f5a-add0-52ee4f558de2","city":"Palo Alto","address":"1845 El Camino Real, Palo Alto, CA 94306, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District","news":[{"id":"c83089f2-ac46-4a46-8ca0-79bac9f9ebbf","date":"Nov 2, 2021","link":"https://www.calcalist.co.il/conferences/article/hjjg4oaly?_atscid=7_134353_204082920_2005328_0_Txtetaxjxdshwhus8sp","source":"www.calcalist.co.il","visible":1,"analysis":{"tags":"food allergies","company":"Ukko","layoffs":null,"summary":"Ukko, an American-Israeli company, has developed safe gluten and proteins for individuals with food allergies. The company uses genetic engineering to produce safe proteins that retain their beneficial properties while eliminating the harmful ones. Ukko focuses on addressing gluten sensitivity, a condition that affects individuals with celiac disease. The company has also developed medications for other food allergies, such as nut allergies. Ukko has raised $48 million in funding and is supported by various companies, including Baer. The goal of Ukko is to create a healthier and safer world for everyone.","partners":"Baer","customers":null,"investors":"Baer","confidence":8,"key_topics":["gluten","food allergies","safe proteins","genetic engineering","healthcare"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$48 million","structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QzrwzoOpRtgiIEiJrVDCKtlWqXxyT7D4NyvaFZeGSbblK62QS1Yk1C","news_summary":"\"פיתחנו גלוטן בטוח עבור חולי צליאק שמספרם מכפיל את עצמו כל כמה שנים\"  כלכליסט","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"eLUHTILqST7wkpv5xmLpeK9iK5Whh0KVUhmeLYxI66AnudJ6dC6Lzq","date":"Apr 14, 2021","link":"https://www.haaretz.com/israel-news/tech-news/2021-04-14/ty-article-magazine/.premium/these-israelis-are-reprogramming-wheat-to-stop-celiac/0000017f-dbfb-db22-a17f-fffb7cfc0000","source":"www.haaretz.com","visible":1,"analysis":{"tags":"Investment, Research, Expansion","company":"Ukko","layoffs":"Not mentioned","summary":"Ukko, an Israeli startup, is using artificial intelligence to redesign gluten and peanut proteins to help those with celiac disease and peanut allergies. The company has engineered a gluten protein that does not contain the component that triggers an immune response in celiac patients. In addition, Ukko is working on modifying peanut proteins to neutralize their ability to trigger allergic reactions. The company has raised $40 million in a funding round led by Bayer and Khosla Ventures. The funds will be used to move from initial development to clinical trials within the next two years.","partners":"Not mentioned","customers":"Not mentioned","investors":["Bayer","Khosla Ventures"],"confidence":9,"key_topics":["Gluten Sensitivity","Peanut Allergy","Protein Modification","Artificial Intelligence","Clinical Trials"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"GbZ1pPTCqMu0R7xKioHj8CgKokl92qkMezP4h2ql7rxvPsX6Sg88Ec","news_summary":"The Israeli startup trying to reimagine wheat","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5fa1c75a-b494-49ce-93ec-b40870436015","date":"Jan 27, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889894,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"biotechnology, food proteins, funding","company":"Ukko","layoffs":null,"summary":"Israeli biotechnology startup Ukko has completed a $40 million series B funding round led by Leaps by Bayer. The company uses patient data, machine learning, and AI to engineer food proteins for food products, plants, and therapeutics. The funding will be used to expand Ukkos teams in the U.S. and Israel and accelerate the development of unique food proteins, with a focus on peanut and gluten-related disorders. Ukko also plans to conduct clinical trials in Israel for medicine to fight against allergies. The company was founded in 2016 by Anat Binur and Yanay Ofran.","partners":null,"customers":null,"investors":"Leaps by Bayer, Continental Grain Company, PeakBridge Ventures, Skyviews LifeScience, Fall Line Capital, Khosla Ventures, Innovation Endeavors, Marc Benioff","confidence":9,"key_topics":["Ukko","funding","food proteins","allergies","expansion"],"date_of_event":"2021-01-27","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"GBY7msSOd1r8PcfpBkANN1xjdLT12fWfTrPZukSiheVYEnmPAs3VSR","news_summary":"Ukko raises $40 million to develop solutions for food allergies and sensitivities","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5fa1c75a-b494-49ce-93ec-b40870436015","date":"Jan 27, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889894,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"biotechnology, food proteins, funding round","company":"Ukko","layoffs":null,"summary":"Israeli biotechnology startup Ukko has completed a $40 million series B funding round led by Leaps by Bayer. The company uses patient data, machine learning, and AI to engineer food proteins that can be incorporated into food products, plants, and therapeutics. The funding will be used to expand Ukkos teams in the U.S. and Israel and accelerate the development of unique food proteins, with a focus on peanut and gluten-related disorders. Ukko plans to manufacture bread and pastries that are safe for people with Celiac disease and conduct clinical trials for medicine to fight against allergies. The company was founded in 2016 by Anat Binur and Yanay Ofran.","partners":null,"customers":null,"investors":"Leaps by Bayer, Continental Grain Company, PeakBridge Ventures, Skyviews LifeScience, Fall Line Capital, Khosla Ventures, Innovation Endeavors, Marc Benioff","confidence":9,"key_topics":["Ukko","funding round","food proteins","allergies","expansion"],"date_of_event":"27.01.21","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"x2Y5cxp0kbK249gc1S78MeukXFQs12hYRkOuLpvbb1pU45Ou8XK030","news_summary":"Ukko raises $40 million to develop solutions for food allergies and sensitivities","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"37493de8-3164-4d74-a9b5-5a35e5353438","date":"Jan 27, 2021","link":"https://agfundernews.com/ukko-anti-allergy-foodtech-startup-scores-40m-in-bayer-led-series-b.html","source":"agfundernews.com","visible":1,"analysis":{"tags":["biotech","food allergies","funding"],"company":"Ukko","layoffs":null,"summary":"Israeli biotech startup Ukko has raised $40 million in a Series B round led by Bayers corporate venture unit, Leaps by Bayer. The funding will be used to develop functional food ingredients and therapeutics to eliminate food allergies and sensitivities, with an initial focus on gluten and peanut allergies. Ukkos approach combines artificial intelligence and bio-engineering to alter food proteins in a way that eliminates their ability to trigger allergies while maintaining their nutritional characteristics. The company aims to enter clinical trials for its investigational therapeutic for peanut allergy. The funding round included participation from several investors, including Continental Grain Company, PeakBridge Ventures, Skyviews Life Science, and Fall Line Capital.","partners":null,"customers":null,"investors":["Bayer","Continental Grain Company","PeakBridge Ventures","Skyviews Life Science","Fall Line Capital","Khosla Ventures","Innovation Endeavors","TIME Ventures"],"confidence":9,"key_topics":["biotech","food allergies","funding","artificial intelligence","therapeutics"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"52M94hRlzqJhhODUzV1Eqwo0RRHI2LPFyU00RN65kvVxyZHX8madlv","news_summary":"Ukko scores $40m in Bayer-led Series B for anti-allergy foodtech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"90fbf5d4-f518-4fe4-9cbd-fe2c6a0c8c61","date":"Jan 27, 2021","link":"https://www.forbes.com/sites/johncumbers/2021/01/27/synthetic-biology-partners-with-ai-to-delete-food-allergies/?sh=9bc849ec6a09 ","source":"www.forbes.com","visible":1,"analysis":{"tags":"food allergies","company":"Ukko","layoffs":null,"summary":"Israeli startup Ukko has raised $40 million in a Series B funding round led by Leaps by Bayer to develop hypoallergenic proteins for people with food allergies. Ukko aims to create proteins that cannot cause allergic reactions, focusing first on peanuts and gluten. For peanuts, Ukko plans to develop hypoallergenic peanut proteins for immunotherapy, allowing those with severe allergies to build up tolerance. For gluten, Ukko aims to create hypoallergenic protein ingredients for food, making gluten-rich dishes safe for people with gluten sensitivities and celiac disease. The funding will support Ukkos efforts to advance its peanut proteins into clinical testing and prepare its products for market entry.","partners":null,"customers":null,"investors":"Leaps by Bayer","confidence":9,"key_topics":["food allergies","hypoallergenic proteins","gluten","peanuts","immunotherapy"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$40 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YYLqWkBTP670IFdwKs1CUNJV76xHXUiZtNDDrRXnBabDOCdqiVBCbJ","news_summary":"Synthetic Biology Partners With AI To Delete Food Allergies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":5,"techcommunityinvolvement":null,"mediagallery":[],"tags":["biotechnology","foodtech","food-ingredients","molecular-biology","consumers","big-data","pharmaceuticals","therapeutics","immunology","allergy","proteins","artificial-intelligence"],"classificationIDs":["v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom7sKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":[],"geomarkets":["Israel","United States"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":11,"lastfunding":"Undisclosed","totalrounds":3,"fundingstage":"A","totalfunding":"$47.7M","publicinvestors":11,"lastpublicfunding":0,"totalpublicrounds":3,"totalpublicfunding":47700000},"team":[{"name":"Yanay Ofran","email":"yanay@ukko.us","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNv5mvYIDA","bounced":false,"claimed":0,"founder":1,"urlname":"yanay-ofran","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg-9aD2QsM","position":"Co-founder & Chairman","last_name":"Ofran","claimtoken":"H8ZNpxls9lhQBnxqNi14Lubt9419fnooEQFAfanij9WY5kgNtMG0Ka","first_name":"Yanay","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/yanay-ofran-1ab72955/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-04 15:44:10.000000","initials":"YO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Anat  Binur","email":"anat@ukko.us","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNvTwLsKDA","bounced":false,"claimed":0,"founder":1,"urlname":"anat-binur","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgu_7llgkM","position":"Co-founder & CEO","last_name":"Binur","claimtoken":"SHv9QOUS7Ug5fhhxwTaqVyOCAHBNBBDlXPraOkOA5OdDRn08LHf5ck","first_name":"Anat ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/anatbinur/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-04 15:42:59.000000","initials":"AB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Moshe Ben-David","email":"moshe@ukko.us","phone":"","gender":"Male","userid":"LUc7s8Fj3IbrCJogDCpJGvQnjpGgifF1adWr6mdqvXCBCwDr4kFtHS","bounced":false,"claimed":null,"founder":0,"urlname":"moshe-ben-david","visible":1,"memberid":"jzpmzMqMgIRd7Bam5C9JpHHvWhzY9EpJP2X94ql0ui0OUcVnyG1ssP","position":"CTO","last_name":"Ben-David","claimtoken":"od3Mb9Fj8bPmtIe5t5llReQG8alAk9K9znCKL2jrxMv77OcPHyMbtz","first_name":"Moshe","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/moshebendavid/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-09-04 15:47:02.000000","initials":"MB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Judith Weiss Paltiel","email":"Judith@ukko.us","phone":"","gender":"Female","userid":"ONYt6M12DK7WTwCZXJ70JiAccG4d3NVC0yFiW3eOHsi9v9JzkiCQSs","bounced":false,"claimed":null,"founder":0,"urlname":"judith-weiss-paltiel","visible":1,"memberid":"pzz5yx887JJPThDVqPKNA1erj9PeUy9NVk1TsN35gF2KpQcxy3jnSP","position":"VP Development","last_name":"Weiss Paltiel","claimtoken":"GEUloopj9wsd5T78GK3ZPDL7bhXHoQ1NjHoFjOKIoNF4AsHDAXsTwK","first_name":"Judith","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/judith-weiss-paltiel-974904b9/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-09-04 15:47:57.000000","initials":"JW","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Leora Bachrach","email":"leora@ukko.us","phone":"","gender":"Female","userid":"m3FfCDzgzMZCcgpZ1q9u88C14Cm3OHO1uWs4zMu2Qc37cfyXH6zYkV","bounced":true,"claimed":null,"founder":0,"urlname":"leora-bachrach-2","visible":1,"memberid":"LDn67XJzadL2jaKEt4bKyZ9H2roaJBVWvofh5NmcLyvKZ8alKGXovL","position":"VP of HR","last_name":"Bachrach","claimtoken":"SU5Cn7iW3FcbKe9HxY29v7IgPCwy3xs3flUa4UyqzmTRQoLYj7tdRv","first_name":"Leora","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/leora-bachrach/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-09-04 15:45:33.000000","initials":"LB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Tal Azriel","email":"azriel.tal@gmail.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4Kjm-JsKDA","bounced":false,"claimed":1,"founder":0,"urlname":"tal-azriel","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgq5OU_gkM","position":"Project Management Officer","last_name":"Azriel","claimtoken":"196e26ec67fe2af3287fa1f20e7a21811b4555cc602e8b5b9eea863745210680","first_name":"Tal","picturekey":"$BBqqTYB8DaFsb7La0Yr72tea96GujLoe16drZsRuSINoE2Tyrx6PCq","claimeddate":"2021-01-31","linkedinurl":"https://www.linkedin.com/in/tal-azriel-285a5113a","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-31 09:47:52.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$BBqqTYB8DaFsb7La0Yr72tea96GujLoe16drZsRuSINoE2Tyrx6PCq","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"}],"description_edited":1,"tag_line_edited":1,"sector":"Agro and Food Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgKPMgJAKDA","fullname":"Shmuel (Sam) Rausnitz"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLGr0IIIDA","fullname":"Yamila Silbert"},"biverifydate":"2019-10-10T00:00:00.000Z","crunchbaseid":"ukko","lastupdator":"Ortal Wein","lastupdator_email":"ortalw@sncentral.org","creator":"Hilla Gorokhovsky","creator_email":"hilla.gorokhovsky@sncentral.org","createdate":"2019-02-17T00:00:00.000Z","biverification":"Yamila Silbert","sectorverification":"Shmuel (Sam) Rausnitz","affiliatedOrganizations":null,"timeline":[{"id":"GWV4SNtfHsB9ETzzIDvPNt9kw4A5FDRdgPDlJHnzDeZVwDjSb0l5ue","date":"Jun 2025","amount":"Undisclosed","source":"Silent round - Eli Yered from Sanara Capital","eventtype":"FundingRoundEvent","investment":[{"name":"Sanara Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sanara-capital","logokey":"$OtrwiBbgsSI76jjQf5e00ig2pAnDSClBhkfRBSLW92Zf7whDq9YrQr.jpeg","tagline":null,"urlname":"/investor_page/sanara-capital","isisraeli":1,"investorid":"5xOGxLkkR8sf5lZkhz50eFzCcebcLx4AdZMgruBnsbEkjIOO0mLnkG","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"19475SrSXNb73yQXI6d2WqvBsChpBHpaljDCrucBC6IGQSF4fFipJS","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OtrwiBbgsSI76jjQf5e00ig2pAnDSClBhkfRBSLW92Zf7whDq9YrQr.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODL9JuECgw","date":"Jan 2021","amount":"$40M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889894,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Leaps by Bayer","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/leaps-by-bayer","logokey":"$obz6WaLWSiwl4WB10bGpnUumGpUcKe8WM58nAw4u5hLHgG2rEkavRZ","tagline":"","urlname":"/investor_page/leaps-by-bayer","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCj09WJCww","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"fbdb1676-25f9-4b5a-8c44-496bc5af4ddc","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$obz6WaLWSiwl4WB10bGpnUumGpUcKe8WM58nAw4u5hLHgG2rEkavRZ","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Khosla Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"19a5634e-7bef-462a-b085-af25cda07fde","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"PeakBridge ","type":"Investor","amount":3000000,"hidden":false,"country":"Malta","fullurl":"/investor_page/peakbridge","logokey":"$7g6y7WLW8ksHDLnAR9ZaODPaofkXM2GlyhL8F9DBoc4FhJXOzeMIr0","tagline":null,"urlname":"/investor_page/peakbridge","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JHTkIAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1f6a59e2-25fc-4d43-8b83-3ea46af20732","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7g6y7WLW8ksHDLnAR9ZaODPaofkXM2GlyhL8F9DBoc4FhJXOzeMIr0","leadcaption":"","followupcaption":""},{"name":"Fall Line Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/fall-line-capital","logokey":"$2Keh3oCrmh01eSQI01LsB9OGbk3Pa3i4YvqtX4C4kqvftpjlzJvUgR","tagline":"","urlname":"/investor_page/fall-line-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCryOGYCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2d1e9506-49bc-4263-8c47-7562e0e5e922","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2Keh3oCrmh01eSQI01LsB9OGbk3Pa3i4YvqtX4C4kqvftpjlzJvUgR","leadcaption":"","followupcaption":""},{"name":"Continental Grain Company","type":"Company","amount":0,"hidden":true,"country":"Belgium","fullurl":"/company_page/continental-grain-company","logokey":"$uzSSL1hgo1lmazSA6FNT459SQUO9zOMU6MD8N3hftVolCHzkJh3XAX","tagline":"Grain-trading Firm","urlname":"/company_page/continental-grain-company","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODLtNTuCww","fundingtype":"Company","leadpartner":null,"investmentid":"5dd498fb-04db-47a3-b097-695c92bdba79","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uzSSL1hgo1lmazSA6FNT459SQUO9zOMU6MD8N3hftVolCHzkJh3XAX","leadcaption":"","followupcaption":""},{"name":"Skyviews LifeScience","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/skyviews-lifescience","logokey":"$9Qg3UMLdnI9W3oO1tqofcQLoCFYTFeQgFAKz8fVs0u3GW5tgs5ivJd","tagline":"","urlname":"/investor_page/skyviews-lifescience","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCzi-WzCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"936e53c3-6662-4fc5-9ba4-5eec97f0be8b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9Qg3UMLdnI9W3oO1tqofcQLoCFYTFeQgFAKz8fVs0u3GW5tgs5ivJd","leadcaption":"","followupcaption":""},{"name":"Innovation Endeavors","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/innovation-endeavors","logokey":"$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","tagline":null,"urlname":"/investor_page/innovation-endeavors","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgIGY9dwKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9d77f473-7c80-496d-a941-d4286db6e7b7","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Marc Benioff","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/marc-benioff","logokey":"$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","tagline":"","urlname":"/investor_page/marc-benioff","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqJX7CQw","fundingtype":"Angel","leadpartner":null,"investmentid":"afb32005-976c-4ff6-9b12-72110d29d3a2","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":40000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWxCww","date":"Jul 2017","amount":"$7.7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Marc Benioff","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/marc-benioff","logokey":"$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","tagline":"","urlname":"/investor_page/marc-benioff","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqJX7CQw","fundingtype":"Angel","leadpartner":null,"investmentid":"5c559df5-dbd0-487b-bcb3-56f4d13c0ed6","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","leadcaption":"","followupcaption":""},{"name":"Izhar Armony","type":"Investor","amount":0,"hidden":false,"country":"US","fullurl":"/investor_page/izhar-armony","logokey":null,"tagline":"","urlname":"/investor_page/izhar-armony","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkw7-qCww","fundingtype":"Angel","leadpartner":null,"investmentid":"7d08e1d6-c1f5-4158-9a69-1b76a363080c","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Khosla Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"dc3f4e64-7009-4211-91ae-51804c0a5408","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","leadcaption":"","followupcaption":""},{"name":"Innovation Endeavors","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/innovation-endeavors","logokey":"$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","tagline":null,"urlname":"/investor_page/innovation-endeavors","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgIGY9dwKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f8f22939-6acb-4566-8d9d-218c9b82f647","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","leadcaption":"","followupcaption":""},{"name":"Slow Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/slow-ventures","logokey":"$wPVm0sPUGjWRUiEpN20UsiHO7likxF3Qu3lLMEr6T3i3PbbeD4VvaI.jpeg","tagline":null,"urlname":"/investor_page/slow-ventures","isisraeli":0,"investorid":"TUpDWGcwIxcoQsjncrbYeK4z68T94r4QToe1Wc3jCA6Ztcc1OYusmS","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"xkbJgV84smT91snmxL7XSk5zASbGJKiP5p86lgQUAU970lwn3p0ACe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wPVm0sPUGjWRUiEpN20UsiHO7likxF3Qu3lLMEr6T3i3PbbeD4VvaI.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"5/2016","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Ukko","logourl":"https://storage.googleapis.com/clean-finder-353810/$BhBe0G4xYOtNeEVW8Z6pftsPckL76OqaHmPYNk2mumwwRKjcUNNM3T","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$BhBe0G4xYOtNeEVW8Z6pftsPckL76OqaHmPYNk2mumwwRKjcUNNM3T","seoabout":"Ukko's mission is to improve the lives of people with food allergies and sensitivities. Ukko uses immunology, machine learning, and protein engineering to ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Agriculture & Food Technologies","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Food Tech","queryString":"sectorclassification=v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","classificationName":"sectorclassification"},{"depth":3,"name":"Novel Food & Ingredients","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Ingredients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom7sKDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp>Novel Food & Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA>Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom7sKDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA|2:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA/Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp|3:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp/Novel Food & Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|1:>IndustryClassificationModel/Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA|2:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA/Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA|3:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA/Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom7sKDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|","classificationTrees":{"sector":[{"title":"Agriculture & Food Technologies","key":"0-0","path":"SectorClassificationModel>Agriculture & Food Technologies","children":[{"title":"Food Tech","key":"0-0-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Food Tech","children":[{"title":"Novel Food & Ingredients","key":"0-0-0-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Food Tech>Novel Food & Ingredients"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]},{"title":"Agriculture & Food","key":"0-1","path":"IndustryClassificationModel>Agriculture & Food","children":[{"title":"Processed Foods","key":"0-1-0","path":"IndustryClassificationModel>Agriculture & Food>Processed Foods","children":[{"title":"Ingredients","key":"0-1-0-0","path":"IndustryClassificationModel>Agriculture & Food>Processed Foods>Ingredients"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence"},{"title":"Biologicals","key":"0-1","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Food Tech","queryString":"sectorclassification=v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","classificationName":"sectorclassification"},{"depth":3,"name":"Novel Food & Ingredients","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Ingredients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puom7sKDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Agriculture & Food Technologies","Food Tech","Novel Food & Ingredients"],"coreTechnology":["Artificial Intelligence","Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Agriculture & Food","Processed Foods","Ingredients"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"GWV4SNtfHsB9ETzzIDvPNt9kw4A5FDRdgPDlJHnzDeZVwDjSb0l5ue","date":"Jun 2025","amount":"Undisclosed","source":"Silent round - Eli Yered from Sanara Capital","eventtype":"FundingRoundEvent","investment":[{"name":"Sanara Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sanara-capital","logokey":"$OtrwiBbgsSI76jjQf5e00ig2pAnDSClBhkfRBSLW92Zf7whDq9YrQr.jpeg","tagline":null,"urlname":"/investor_page/sanara-capital","isisraeli":1,"investorid":"5xOGxLkkR8sf5lZkhz50eFzCcebcLx4AdZMgruBnsbEkjIOO0mLnkG","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"19475SrSXNb73yQXI6d2WqvBsChpBHpaljDCrucBC6IGQSF4fFipJS","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OtrwiBbgsSI76jjQf5e00ig2pAnDSClBhkfRBSLW92Zf7whDq9YrQr.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODL9JuECgw","date":"Jan 2021","amount":"$40M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3889894,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Leaps by Bayer","type":"Investor","amount":0,"hidden":false,"country":"Germany","fullurl":"/investor_page/leaps-by-bayer","logokey":"$obz6WaLWSiwl4WB10bGpnUumGpUcKe8WM58nAw4u5hLHgG2rEkavRZ","tagline":"","urlname":"/investor_page/leaps-by-bayer","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCj09WJCww","fundingtype":"Corporate VC","leadpartner":null,"investmentid":"fbdb1676-25f9-4b5a-8c44-496bc5af4ddc","fundingsubtype":"Corporate VC","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$obz6WaLWSiwl4WB10bGpnUumGpUcKe8WM58nAw4u5hLHgG2rEkavRZ","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Khosla Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"19a5634e-7bef-462a-b085-af25cda07fde","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"PeakBridge ","type":"Investor","amount":3000000,"hidden":false,"country":"Malta","fullurl":"/investor_page/peakbridge","logokey":"$7g6y7WLW8ksHDLnAR9ZaODPaofkXM2GlyhL8F9DBoc4FhJXOzeMIr0","tagline":null,"urlname":"/investor_page/peakbridge","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JHTkIAKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1f6a59e2-25fc-4d43-8b83-3ea46af20732","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7g6y7WLW8ksHDLnAR9ZaODPaofkXM2GlyhL8F9DBoc4FhJXOzeMIr0","leadcaption":"","followupcaption":""},{"name":"Fall Line Capital","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/fall-line-capital","logokey":"$2Keh3oCrmh01eSQI01LsB9OGbk3Pa3i4YvqtX4C4kqvftpjlzJvUgR","tagline":"","urlname":"/investor_page/fall-line-capital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCryOGYCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2d1e9506-49bc-4263-8c47-7562e0e5e922","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2Keh3oCrmh01eSQI01LsB9OGbk3Pa3i4YvqtX4C4kqvftpjlzJvUgR","leadcaption":"","followupcaption":""},{"name":"Continental Grain Company","type":"Company","amount":0,"hidden":true,"country":"Belgium","fullurl":"/company_page/continental-grain-company","logokey":"$uzSSL1hgo1lmazSA6FNT459SQUO9zOMU6MD8N3hftVolCHzkJh3XAX","tagline":"Grain-trading Firm","urlname":"/company_page/continental-grain-company","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODLtNTuCww","fundingtype":"Company","leadpartner":null,"investmentid":"5dd498fb-04db-47a3-b097-695c92bdba79","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$uzSSL1hgo1lmazSA6FNT459SQUO9zOMU6MD8N3hftVolCHzkJh3XAX","leadcaption":"","followupcaption":""},{"name":"Skyviews LifeScience","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/skyviews-lifescience","logokey":"$9Qg3UMLdnI9W3oO1tqofcQLoCFYTFeQgFAKz8fVs0u3GW5tgs5ivJd","tagline":"","urlname":"/investor_page/skyviews-lifescience","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCzi-WzCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"936e53c3-6662-4fc5-9ba4-5eec97f0be8b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$9Qg3UMLdnI9W3oO1tqofcQLoCFYTFeQgFAKz8fVs0u3GW5tgs5ivJd","leadcaption":"","followupcaption":""},{"name":"Innovation Endeavors","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/innovation-endeavors","logokey":"$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","tagline":null,"urlname":"/investor_page/innovation-endeavors","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgIGY9dwKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9d77f473-7c80-496d-a941-d4286db6e7b7","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Marc Benioff","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/marc-benioff","logokey":"$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","tagline":"","urlname":"/investor_page/marc-benioff","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqJX7CQw","fundingtype":"Angel","leadpartner":null,"investmentid":"afb32005-976c-4ff6-9b12-72110d29d3a2","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":40000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7qWxCww","date":"Jul 2017","amount":"$7.7M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Marc Benioff","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/marc-benioff","logokey":"$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","tagline":"","urlname":"/investor_page/marc-benioff","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqJX7CQw","fundingtype":"Angel","leadpartner":null,"investmentid":"5c559df5-dbd0-487b-bcb3-56f4d13c0ed6","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YBDHYVPBUWrjfm1DT9rfyznLAA41VemBEUA4F8yvNczISOFBgbLNFI","leadcaption":"","followupcaption":""},{"name":"Izhar Armony","type":"Investor","amount":0,"hidden":false,"country":"US","fullurl":"/investor_page/izhar-armony","logokey":null,"tagline":"","urlname":"/investor_page/izhar-armony","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCkw7-qCww","fundingtype":"Angel","leadpartner":null,"investmentid":"7d08e1d6-c1f5-4158-9a69-1b76a363080c","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""},{"name":"Khosla Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"dc3f4e64-7009-4211-91ae-51804c0a5408","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","leadcaption":"","followupcaption":""},{"name":"Innovation Endeavors","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/innovation-endeavors","logokey":"$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","tagline":null,"urlname":"/investor_page/innovation-endeavors","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgIGY9dwKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"f8f22939-6acb-4566-8d9d-218c9b82f647","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4TQKs5g0HnJkWbszwogIexVklK8DsfMdIsUxph58IdxqKTy6Lon5pr","leadcaption":"","followupcaption":""},{"name":"Slow Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/slow-ventures","logokey":"$wPVm0sPUGjWRUiEpN20UsiHO7likxF3Qu3lLMEr6T3i3PbbeD4VvaI.jpeg","tagline":null,"urlname":"/investor_page/slow-ventures","isisraeli":0,"investorid":"TUpDWGcwIxcoQsjncrbYeK4z68T94r4QToe1Wc3jCA6Ztcc1OYusmS","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"xkbJgV84smT91snmxL7XSk5zASbGJKiP5p86lgQUAU970lwn3p0ACe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$wPVm0sPUGjWRUiEpN20UsiHO7likxF3Qu3lLMEr6T3i3PbbeD4VvaI.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}